End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 NZD | 0.00% | -2.91% | -14.29% |
May. 01 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
Apr. 24 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 189M | |
+26.08% | 662B | |
+22.63% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.56% | 198B | |
-10.67% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment